EBC is a network of key players in the “Brain Area”, with a membership encompassing scientific societies, patient organisations, professional societies and industry partners.
News2020-06-23T14:44:25+00:00

Latest News

2905-2022

Neurological disorders become a major global health priority

29-05-2022|News|

Supporting the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders The members of the OneNeurology partnership celebrate a major milestone for all those affected by neurological disorders today, with the adoption of the Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders, announced at last week’s 75th World Health Assembly. We fully endorse its aims, will support [...]

2905-2022

EBC launches 2021 annual report

29-05-2022|News|

We are delighted to share with you the EBC Annual Report for 2021. Despite the ongoing COVID-19 pandemic, we are pleased to have managed to continue to successfully conduct and pursue ongoing projects such as: the Value of Innovation (from which stemmed the development of the EBC Policy Roadmap), MULTI-ACT and the European Brain Research Area (EBRA). In addition, [...]

2405-2022

RETHINKING Alzheimer’s disease project, calling for change in Alzheimer’s care, kicks off!

24-05-2022|News|

Through RETHINKING Alzheimer’s disease (AD), the European Brain Council (EBC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) are joining forces with the ambition of improving Alzheimer’s disease care pathway and the lives of people living with it. Officially launched on 29 April 2022, the project kicked off its operational activities with the aim to call for [...]

2504-2022

Visit the extended exhibition “Living with MS during COVID-19: A case for rethinking MS care in the EU”

25-04-2022|News|

On the occasion of Multiple Sclerosis Awareness Week 2022, the national extension of the virtual exhibition "Living with MS during COVID-19: A case for rethinking MS care in the EU" brings light to the impact of the COVID-19 pandemic on multiple sclerosis at country level. Impact of the COVID-19 pandemic on multiple sclerosis at national level The COVID-19 pandemic [...]

2303-2022

EBRA launches open consultation on Shared European Brain Research Agenda

23-03-2022|News|

The preparation of the Shared European Brain Research Agenda (SEBRA) is currently underway within the EBC-coordinated European Brain Research Area (EBRA) project, with the aim to provide recommendations on future areas for excellent, innovative, and translational research. Existing strategic research agendas have been taken into consideration and input has been collected from a first set of identified experts in the European brain research area. A Consultation is now open on this first draft [...]

2203-2022

EBC celebrates 20 years!

22-03-2022|News|

Twenty years ago to this day, the European Brain Council (EBC) was formed. The brain child of Prof.  Jes Olesen, EBC was the answer to the need for increased unity within the brain community, building a more connected network of key players in the brain space — scientists, clinicians, patients, industry — encompassing basic neuroscience, neurology, neurosurgery and psychiatry. [...]

1803-2022

A look back at Brain Awareness Week 2022

18-03-2022|News|

Brain Awareness Week 2022 was a busy time period for EBC this year, with a series of virtual launches taking place, namely the release of the 2nd Round of the Value of Treatment project results and Calls to Action as well as the Save the Date for two major events later this year. On Monday, 14 March, the Value of [...]

1403-2022

Value of Treatment project releases results and calls to action on the occasion of Brain Awareness Week 2022

14-03-2022|News|

On the occasion of Brain Awareness Week 2022, the EBC-led Value of Treatment project – currently in its second round – releases results and calls to action this week. The Value of Treatment for Brain Disorders (VOT) is a health economics and outcomes research project launched in 2015, with the objective to identify treatment gaps (or barriers to care) [...]

Go to Top